Article
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Journal of clinical microbiology - 1 Jul 2012
Park Yongjung, Lee Eunhee, Choi Jonghyeon, Jeong Seri, Kim Hyon-Suk
Abstract excerpt
Infection with high-risk (HR) human papillomavirus (HPV) genotypes is an important risk factor for cervical cancers. We evaluated the clinical performances of two new real-time PCR assays for detecting HR HPVs compared to that of the Hybrid Capture 2 test (HC2). A total of 356 cervical swab specimens, which had been examined for cervical cytology, were assayed by Abbott RealTime HR and Roche Cobas HPV as well as...
Topics
- Cervix Uteri
- DNA, Viral
- Female
- Genotype
- Humans
- Molecular Diagnostic Techniques
- Nucleic Acid Hybridization
- Papillomaviridae
- Papillomavirus Infections
- Real-Time Polymerase Chain Reaction
